May 24, 2017
by Lysimachos Zografos
Comments Off on Parkure’s pipeline news: two drugs pre-clicanically validated.

Parkure’s pipeline news: two drugs pre-clicanically validated.

Two key pipeline compounds discovered by Parkure have been pre-clinically validated as part of a collaboration with Charles River Laboratories. Both drugs were found to rescue the symptoms of a virally induced rat model of Parkinson’s disease. Beyond the progress for … Continue reading

April 21, 2017
by Lysimachos Zografos
Comments Off on New paper out

New paper out

We are committed to Parkinson’s research and our new paper on repurposing Astemizole and Ketoconazole is out (and free to access until May the 5th). Abstract: Parkinson’s disease is a growing threat to an ever-ageing population. Despite progress in our understanding of the … Continue reading

April 11, 2017
by Lysimachos Zografos
Comments Off on Parkure at biotrinity 2017 London

Parkure at biotrinity 2017 London

Parkure will be one of the selected companies presenting at biotrinity 2017 in London. If you are attending the meeting you can catch our presentation  on Wednesday April 10th at 10:10 (early stage therapeutics track).

June 30, 2016
by Lysimachos Zografos
Comments Off on Parkure secures Innovation Voucher

Parkure secures Innovation Voucher

We are happy to announce that we have secured an Innovation Voucher in order to take the first steps into developing more novel tools and methods for in-vivo drug discovery.

June 30, 2016
by Lysimachos Zografos
Comments Off on Parkure receives investment

Parkure receives investment

We are happy to officially announce that Parkure successfully raised an investment from Deepbride Capital LLP ( (DBC). DBC’s team includes experienced professionals in the field of Life Sciences and Technology. DBC will work closely with the management at Parkure to … Continue reading

June 30, 2016
by Lysimachos Zografos
Comments Off on Life is people

Life is people

Our friend Simon shared this great video that his daughter Eliza produced. Working on drug discovery means that we have to deal with how nasty Parkinson’s is at the molecular and medical level on a daily basis. Watching this reminded … Continue reading

February 3, 2015
by Lysimachos Zografos
Comments Off on Parkure’s CEO awarded fellowship from Royal Society of Edinburgh

Parkure’s CEO awarded fellowship from Royal Society of Edinburgh

The Royal Society of Edinburgh (RSE) is Scotland’s national academy of science and letters. As part of their invaluable support to Scottish Life Sciences they offer Enterprise Fellowships in order to enable promising science and technology researchers to grow into successful … Continue reading

February 3, 2015
by Lysimachos Zografos
Comments Off on Parkure at EIE15

Parkure at EIE15

We are delighted to announce that Parkure will be at this year’s instalment of Engage Invest Exploit (EIE15), Scotland’s premier technology investor showcase. EIE15 is organised by University of Edinburgh Informatics Ventures and offers the opportunity to a few selected companies … Continue reading